Cargando…
Molecular Targeted Agents for Gastric Cancer: A Step Forward Towards Personalized Therapy
Gastric cancer (GC) represents a major cancer burden worldwide, and remains the second leading cause of cancer-related death. Due to its insidious nature, presentation is usually late and often carries a poor prognosis. Despite having improved treatment modalities over the last decade, for most pati...
Autores principales: | Cidon, Esther Una, Ellis, Sara G, Inam, Yasir, Adeleke, Sola, Zarif, Sara, Geldart, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730303/ https://www.ncbi.nlm.nih.gov/pubmed/24216699 http://dx.doi.org/10.3390/cancers5010064 |
Ejemplares similares
-
Nutritional Status After Total Gastrectomy for Gastric Cancer
por: Cidon, Esther Una
Publicado: (2010) -
Gastric cancer and the search for a good prognostic classification: a challenge
por: Cidón, Esther Uña
Publicado: (2010) -
Gastric Adenocarcinoma: Is Computed Tomography (CT) Useful in Preoperative Staging?
por: Cidón, Esther Uña, et al.
Publicado: (2009) -
A Commentary on “Risk Factors for Renal Cell Cancer in a Japanese Population”
por: Cidon, Esther Uña
Publicado: (2009) -
The Challenge of Metastatic Colorectal Cancer
por: Cidón, Esther Uña
Publicado: (2010)